Kennedy Capital Management LLC Increases Position in Addus HomeCare Corporation $ADUS

Kennedy Capital Management LLC raised its position in Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 11.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 218,341 shares of the company’s stock after purchasing an additional 21,716 shares during the quarter. Kennedy Capital Management LLC’s holdings in Addus HomeCare were worth $23,448,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. TimesSquare Capital Management LLC raised its position in Addus HomeCare by 6.2% in the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after purchasing an additional 24,301 shares during the period. Burney Co. purchased a new stake in shares of Addus HomeCare during the fourth quarter worth $1,841,000. Public Sector Pension Investment Board increased its position in shares of Addus HomeCare by 14.4% during the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock worth $8,357,000 after acquiring an additional 8,893 shares during the period. Capital Research Global Investors increased its position in shares of Addus HomeCare by 9.0% during the third quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock worth $141,772,000 after acquiring an additional 99,262 shares during the period. Finally, Vanguard Group Inc. increased its position in shares of Addus HomeCare by 2.9% during the third quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock worth $153,163,000 after acquiring an additional 36,674 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $93.28 on Friday. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The company has a market cap of $1.74 billion, a P/E ratio of 17.24, a PEG ratio of 1.28 and a beta of 0.89. The firm has a fifty day moving average price of $93.73 and a 200 day moving average price of $103.31.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. During the same quarter in the prior year, the firm posted $1.42 earnings per share. Addus HomeCare’s revenue for the quarter was up 7.7% on a year-over-year basis. Sell-side analysts predict that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Wall Street Zen lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday, February 25th. Weiss Ratings lowered Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 22nd. Finally, Barclays cut their price objective on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.00.

Check Out Our Latest Report on ADUS

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.